Carbohydrate-Deficient Transferrin for Identification of Drug Overdose Patients at Risk of an Alcohol Withdrawal Syndrome
- 1 January 1996
- journal article
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 34 (3) , 297-300
- https://doi.org/10.3109/15563659609013793
Abstract
Chronic alcohol abuse is frequent in patients admitted to the intensive care unit with acute drug overdose. During detoxification, an alcohol withdrawal syndrome may develop in patients with a history of chronic alcohol abuse. Withdrawal or delirium is associated with serious risks, necessitating early identification of patients at risk. Since the information obtained from the patients or their relatives on alcohol consumption is often unreliable, biochemical markers may be helpful. Carbohydrate deficient transferrin is considered a highly specific marker (reported maximum specificity 97%, sensitivity 40-85%) for identifying alcohol abuse. In 20 patients with acute drug overdose and suspected alcohol abuse, carbohydrate deficient transferrin was determined by an immunoturbidimetric assay on admission to the intensive care unit. Eight of the patients had carbohydrate deficient transferrin levels above the "positive" threshold and nine in a suspicious range. A "false" negative carbohydrate deficient transferrin was found in three patients who were thought to have changed their drinking habits prior to hospitalization. A "positive" carbohydrate deficient transferrin test is assumed to be associated with ingestion of more than 60-80 g ethanol/d for a period of more than seven days. In all patients, clonidine (30-210 micrograms/h i.v.) was started. None developed delirium. Since alcohol addiction is frequently denied, determination of carbohydrate deficient transferrin may be useful for its early diagnosis but the sensitivity of this parameter requires further evaluation.Keywords
This publication has 12 references indexed in Scilit:
- Carbohydrate‐Deficient Transferrin as a Measure of Immoderate Drinking: Remaining IssuesAlcohol, Clinical and Experimental Research, 1994
- Carbohydrate‐Deficient Transferrin and γ‐Glutamyltransferase as Markers of Heavy Alcohol Consumption: Gender DifferencesAlcohol, Clinical and Experimental Research, 1994
- Postoperative morbidity among symptom-free alcohol misusersThe Lancet, 1992
- Laboratory Markers of Ethanol Intake and Abuse: A Critical AppraisalThe Lancet Healthy Longevity, 1992
- Screening for Alcohol Abuse Using CAGE Scores and Likelihood RatiosAnnals of Internal Medicine, 1991
- Plasma Norharman (β‐Carboline) Levels are Elevated in Chronic AlcoholicsAlcohol, Clinical and Experimental Research, 1991
- Biological markers for increased risk of alcoholism and for quantitation of alcohol consumption.Journal of Clinical Investigation, 1990
- Harman induces preference for ethanol in rats: Is the effect specific for ethanol?Pharmacology Biochemistry and Behavior, 1987
- Increased excretion of harman by alcoholics depends on events of their life history and the state of the liverPsychopharmacology, 1985
- Increased Blood Acetate: A New Laboratory Marker of Alcoholism and Heavy DrinkingAlcohol, Clinical and Experimental Research, 1985